HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[The PM-Scl (polymyositis-scleroderma) autoantibody and its nucleolar fluorescence pattern].

Abstract
By indirect immunofluorescence studies of antinuclear antibodies on hamster liver imprints as a substrate performed to determine the nuclear staining pattern of sera from patients with connective tissue diseases 10 sera showed a distinct homogeneous nucleolar staining pattern associated with weaker speckled or homogeneous nucleoplasmic fluorescence. In all 10 cases the antibodies revealed the PM-Scl specificity in immunodiffusion. Clinically 9 patients had an acrosclerosis, in 56% overlapped with symptoms of polymyositis. Only one patient had a diffuse scleroderma. The homogeneous nucleolar immunofluorescence pattern of PM-Scl should be distinguished from mixed nucleolar and diffuse reticular nucleoplasmic pattern of Scl-70.
AuthorsG Kühn, M Jarzabek-Chorzelska, M Blaszczyk, Z Kolacinska-Strasz, T P Chorzelski, S Jablonska
JournalDermatologische Monatschrift (Dermatol Monatsschr) Vol. 175 Issue 8 Pg. 479-83 ( 1989) ISSN: 0011-9083 [Print] Germany
Vernacular TitleDer PM-Scl- (Polymyositis-Sklerodermie-) Autoantikörper und sein nukleoläres Fluoreszenzmuster.
PMID2676628 (Publication Type: Journal Article)
Chemical References
  • Antibodies, Antinuclear
  • Nuclear Proteins
  • Scl 70 antigen, human
  • DNA Topoisomerases, Type I
Topics
  • Antibodies, Antinuclear (analysis)
  • Cell Nucleolus (ultrastructure)
  • DNA Topoisomerases, Type I
  • Fluorescent Antibody Technique
  • Humans
  • Myositis (pathology)
  • Nuclear Proteins (immunology)
  • Scleroderma, Systemic (pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: